<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-03" modified="2020-10-07" version="145">
<accession>Q2M2I8</accession>
<accession>Q4ZFZ3</accession>
<accession>Q53RX6</accession>
<accession>Q9UPV4</accession>
<name>AAK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>AP2-associated protein kinase 1</fullName>
<ecNumber evidence="22 23 24 25 28 29">2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Adaptor-associated kinase 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">AAK1</name>
<name type="synonym">KIAA1048</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="2698" last="2706">
<title>A novel AAK1 splice variant functions at multiple steps of the endocytic pathway.</title>
<authorList>
<person name="Henderson D.M."/>
<person name="Conner S.D."/>
</authorList>
<dbReference type="PubMed" id="17494869"/>
<dbReference type="DOI" id="10.1091/mbc.e06-09-0831"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH CLATHRIN AND AP-2</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DOMAIN</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="DNA Res." volume="6" first="197" last="205">
<title>Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Kikuno R."/>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Hirosawa M."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10470851"/>
<dbReference type="DOI" id="10.1093/dnares/6.3.197"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT GLN-509</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT GLN-509</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="J. Cell Biol." volume="156" first="791" last="795">
<title>Phosphorylation of the AP2 mu subunit by AAK1 mediates high affinity binding to membrane protein sorting signals.</title>
<authorList>
<person name="Ricotta D."/>
<person name="Conner S.D."/>
<person name="Schmid S.L."/>
<person name="von Figura K."/>
<person name="Honing S."/>
</authorList>
<dbReference type="PubMed" id="11877457"/>
<dbReference type="DOI" id="10.1083/jcb.200111068"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="J. Cell Biol." volume="156" first="921" last="929">
<title>Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis.</title>
<authorList>
<person name="Conner S.D."/>
<person name="Schmid S.L."/>
</authorList>
<dbReference type="PubMed" id="11877461"/>
<dbReference type="DOI" id="10.1083/jcb.200108123"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="J. Cell Biol." volume="162" first="773" last="779">
<title>Differential requirements for AP-2 in clathrin-mediated endocytosis.</title>
<authorList>
<person name="Conner S.D."/>
<person name="Schmid S.L."/>
</authorList>
<dbReference type="PubMed" id="12952931"/>
<dbReference type="DOI" id="10.1083/jcb.200304069"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH AP-2</scope>
<scope>MUTAGENESIS OF LYS-74 AND ASP-176</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Traffic" volume="4" first="885" last="890">
<title>AAK1-mediated micro2 phosphorylation is stimulated by assembled clathrin.</title>
<authorList>
<person name="Conner S.D."/>
<person name="Schroter T."/>
<person name="Schmid S.L."/>
</authorList>
<dbReference type="PubMed" id="14617351"/>
<dbReference type="DOI" id="10.1046/j.1398-9219.2003.0142.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH CLATHRIN AND AP-2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389 AND THR-606</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="5167" last="5176">
<title>Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.</title>
<authorList>
<person name="Carrascal M."/>
<person name="Ovelleiro D."/>
<person name="Casas V."/>
<person name="Gay M."/>
<person name="Abian J."/>
</authorList>
<dbReference type="PubMed" id="19367720"/>
<dbReference type="DOI" id="10.1021/pr800500r"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389; THR-441; SER-637 AND SER-731</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-234; SER-235; THR-389; THR-606; THR-620; SER-623; SER-624 AND SER-637</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Traffic" volume="9" first="1791" last="1800">
<title>AAK1 regulates Numb function at an early step in clathrin-mediated endocytosis.</title>
<authorList>
<person name="Sorensen E.B."/>
<person name="Conner S.D."/>
</authorList>
<dbReference type="PubMed" id="18657069"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2008.00790.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH NUMB</scope>
<scope>MUTAGENESIS OF LYS-74 AND ASP-176</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; THR-354; THR-389; SER-637; SER-650; TYR-687 AND SER-731</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389; THR-606; SER-637 AND THR-653</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-620; SER-623; SER-624 AND SER-637</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="18720" last="18730">
<title>The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway.</title>
<authorList>
<person name="Gupta-Rossi N."/>
<person name="Ortica S."/>
<person name="Meas-Yedid V."/>
<person name="Heuss S."/>
<person name="Moretti J."/>
<person name="Olivo-Marin J.C."/>
<person name="Israel A."/>
</authorList>
<dbReference type="PubMed" id="21464124"/>
<dbReference type="DOI" id="10.1074/jbc.m110.190769"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EPS15 AND NOTCH1</scope>
<scope>MUTAGENESIS OF LYS-74 AND 777-ASP--PHE-779</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-606; THR-620; SER-624 AND SER-637</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; THR-606; THR-620 AND SER-637</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-620</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2015" name="J. Virol." volume="89" first="4387" last="4404">
<title>AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.</title>
<authorList>
<person name="Neveu G."/>
<person name="Ziv-Av A."/>
<person name="Barouch-Bentov R."/>
<person name="Berkerman E."/>
<person name="Mulholland J."/>
<person name="Einav S."/>
</authorList>
<dbReference type="PubMed" id="25653444"/>
<dbReference type="DOI" id="10.1128/jvi.02705-14"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="27" evidence="1">
<citation type="journal article" date="2016" name="Structure" volume="24" first="401" last="411">
<title>Family-wide Structural Analysis of Human Numb-Associated Protein Kinases.</title>
<authorList>
<person name="Sorrell F.J."/>
<person name="Szklarz M."/>
<person name="Abdul Azeez K.R."/>
<person name="Elkins J.M."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="26853940"/>
<dbReference type="DOI" id="10.1016/j.str.2015.12.015"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 29-345 IN COMPLEX WITH INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="28" evidence="3">
<citation type="submission" date="2016-09" db="PDB data bank">
<title>Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with BIBF 1120.</title>
<authorList>
<person name="Counago R.M."/>
<person name="Elkins J.M."/>
<person name="Arrowsmith C.H."/>
<person name="Bountra C."/>
<person name="Arruda P."/>
<person name="Edwards A.M."/>
<person name="Gileadi O."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 27-365</scope>
</reference>
<reference key="29" evidence="2">
<citation type="journal article" date="2019" name="J. Med. Chem." volume="62" first="5810" last="5831">
<title>Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.</title>
<authorList>
<person name="Verdonck S."/>
<person name="Pu S.Y."/>
<person name="Sorrell F.J."/>
<person name="Elkins J.M."/>
<person name="Froeyen M."/>
<person name="Gao L.J."/>
<person name="Prugar L.I."/>
<person name="Dorosky D.E."/>
<person name="Brannan J.M."/>
<person name="Barouch-Bentov R."/>
<person name="Knapp S."/>
<person name="Dye J.M."/>
<person name="Herdewijn P."/>
<person name="Einav S."/>
<person name="De Jonghe S."/>
</authorList>
<dbReference type="PubMed" id="31136173"/>
<dbReference type="DOI" id="10.1021/acs.jmedchem.9b00136"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.97 ANGSTROMS) OF 27-365</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-59; HIS-533; ALA-603; MET-694; THR-725; ARG-771 AND ASP-835</scope>
</reference>
<comment type="function">
<text evidence="22 23 24 25 28 29 30 31">Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis (PubMed:17494869, PubMed:11877457, PubMed:11877461, PubMed:12952931, PubMed:14617351, PubMed:25653444). Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 (PubMed:17494869). Preferentially, may phosphorylate substrates on threonine residues (PubMed:11877457, PubMed:18657069). Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes (PubMed:12952931). Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes (PubMed:18657069). Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity (PubMed:21464124).</text>
</comment>
<comment type="function">
<text evidence="31 39">(Microbial infection) By regulating clathrin-mediated endocytosis, AAK1 plays a role in the entry of hepatitis C virus as well as for the lifecycle of other viruses such as Ebola and Dengue.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="37">
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="22 23 24 25 28 29 32 33">
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="25 28">Stimulated by clathrin.</text>
</comment>
<comment type="subunit">
<text evidence="17 24 25 28 29 30">Interacts (via CBD domain) with clathrin (PubMed:17494869, PubMed:14617351). Interacts with AP-2 complex (PubMed:17494869, PubMed:12952931, PubMed:14617351). Interacts with NUMB (PubMed:18657069). Interacts with alpha-adaptin (By similarity). Interacts with EPS15 isoform 2 (PubMed:21464124). Interacts with membrane-bound activated NOTCH1 but not with the inactive full-length form of NOTCH1 (PubMed:21464124). Preferentially interacts with monoubiquitinated activated NOTCH1 compared to the non-ubiquitinated form (PubMed:21464124).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383433">
<id>Q2M2I8</id>
</interactant>
<interactant intactId="EBI-6308763">
<id>Q9NQ11</id>
<label>ATP13A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16">Cell membrane</location>
<topology evidence="16">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Membrane</location>
<location evidence="23">Clathrin-coated pit</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Cell junction</location>
<location evidence="17">Synapse</location>
<location evidence="17">Presynapse</location>
</subcellularLocation>
<text evidence="17">Active when found in clathrin-coated pits at the plasma membrane. In neuronal cells, enriched at presynaptic terminals. In non-neuronal cells, enriched at leading edge of migrating cells.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q2M2I8-1</id>
<name>1</name>
<name evidence="36">AAK1L</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q2M2I8-2</id>
<name>2</name>
<name evidence="36">AAK1S</name>
<sequence type="described" ref="VSP_039459"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="28">Detected in brain, heart and liver. Isoform 1 is the predominant isoform in brain.</text>
</comment>
<comment type="PTM">
<text evidence="28">Autophosphorylated.</text>
</comment>
<comment type="pharmaceutical">
<text evidence="38 39">By regulating the entry of hepatitis C virus as well as the lifecycle of other viruses such as Ebola and Dengue, AAK1 is a potential drug target for developing antiviral therapies.</text>
</comment>
<comment type="similarity">
<text evidence="19">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family.</text>
</comment>
<comment type="sequence caution" evidence="37">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA83000" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EC" id="2.7.11.1" evidence="22 23 24 25 28 29"/>
<dbReference type="EMBL" id="AB028971">
<property type="protein sequence ID" value="BAA83000.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC092431">
<property type="protein sequence ID" value="AAX88861.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC079121">
<property type="protein sequence ID" value="AAY14931.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC136007">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC104842">
<property type="protein sequence ID" value="AAI04843.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC111965">
<property type="protein sequence ID" value="AAI11966.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055726.3">
<molecule id="Q2M2I8-1"/>
<property type="nucleotide sequence ID" value="NM_014911.3"/>
</dbReference>
<dbReference type="PDB" id="4WSQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=29-345"/>
</dbReference>
<dbReference type="PDB" id="5L4Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A/B=27-365"/>
</dbReference>
<dbReference type="PDB" id="5TE0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=27-365"/>
</dbReference>
<dbReference type="PDBsum" id="4WSQ"/>
<dbReference type="PDBsum" id="5L4Q"/>
<dbReference type="PDBsum" id="5TE0"/>
<dbReference type="SMR" id="Q2M2I8"/>
<dbReference type="BioGRID" id="116520">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="IntAct" id="Q2M2I8">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="MINT" id="Q2M2I8"/>
<dbReference type="STRING" id="9606.ENSP00000386456"/>
<dbReference type="BindingDB" id="Q2M2I8"/>
<dbReference type="ChEMBL" id="CHEMBL3830"/>
<dbReference type="DrugBank" id="DB12010">
<property type="generic name" value="Fostamatinib"/>
</dbReference>
<dbReference type="DrugCentral" id="Q2M2I8"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1921"/>
<dbReference type="GlyGen" id="Q2M2I8">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q2M2I8"/>
<dbReference type="MetOSite" id="Q2M2I8"/>
<dbReference type="PhosphoSitePlus" id="Q2M2I8"/>
<dbReference type="SwissPalm" id="Q2M2I8"/>
<dbReference type="BioMuta" id="AAK1"/>
<dbReference type="DMDM" id="300669613"/>
<dbReference type="EPD" id="Q2M2I8"/>
<dbReference type="jPOST" id="Q2M2I8"/>
<dbReference type="MassIVE" id="Q2M2I8"/>
<dbReference type="MaxQB" id="Q2M2I8"/>
<dbReference type="PaxDb" id="Q2M2I8"/>
<dbReference type="PeptideAtlas" id="Q2M2I8"/>
<dbReference type="PRIDE" id="Q2M2I8"/>
<dbReference type="ProteomicsDB" id="61355">
<molecule id="Q2M2I8-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="61356">
<molecule id="Q2M2I8-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="7943">
<property type="antibodies" value="344 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000406297">
<molecule id="Q2M2I8-2"/>
<property type="protein sequence ID" value="ENSP00000385181"/>
<property type="gene ID" value="ENSG00000115977"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000409085">
<molecule id="Q2M2I8-1"/>
<property type="protein sequence ID" value="ENSP00000386456"/>
<property type="gene ID" value="ENSG00000115977"/>
</dbReference>
<dbReference type="GeneID" id="22848"/>
<dbReference type="KEGG" id="hsa:22848"/>
<dbReference type="UCSC" id="uc002sfp.3">
<molecule id="Q2M2I8-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="22848"/>
<dbReference type="DisGeNET" id="22848"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000115977.18"/>
<dbReference type="GeneCards" id="AAK1"/>
<dbReference type="HGNC" id="HGNC:19679">
<property type="gene designation" value="AAK1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115977">
<property type="expression patterns" value="Tissue enriched (parathyroid)"/>
</dbReference>
<dbReference type="MIM" id="616405">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q2M2I8"/>
<dbReference type="OpenTargets" id="ENSG00000115977"/>
<dbReference type="PharmGKB" id="PA134990616"/>
<dbReference type="eggNOG" id="KOG1989">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155968"/>
<dbReference type="InParanoid" id="Q2M2I8"/>
<dbReference type="KO" id="K08853"/>
<dbReference type="OMA" id="XIQAPIR"/>
<dbReference type="OrthoDB" id="826336at2759"/>
<dbReference type="PhylomeDB" id="Q2M2I8"/>
<dbReference type="TreeFam" id="TF317300"/>
<dbReference type="PathwayCommons" id="Q2M2I8"/>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="SignaLink" id="Q2M2I8"/>
<dbReference type="SIGNOR" id="Q2M2I8"/>
<dbReference type="BioGRID-ORCS" id="22848">
<property type="hits" value="10 hits in 900 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="AAK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="AAK1"/>
<dbReference type="GenomeRNAi" id="22848"/>
<dbReference type="Pharos" id="Q2M2I8">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q2M2I8"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q2M2I8">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115977">
<property type="expression patterns" value="Expressed in occipital lobe and 249 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q2M2I8">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q2M2I8">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031252">
<property type="term" value="C:cell leading edge"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005905">
<property type="term" value="C:clathrin-coated pit"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030136">
<property type="term" value="C:clathrin-coated vesicle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019897">
<property type="term" value="C:extrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043195">
<property type="term" value="C:terminal bouton"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035612">
<property type="term" value="F:AP-2 adaptor complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005112">
<property type="term" value="F:Notch binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006897">
<property type="term" value="P:endocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045747">
<property type="term" value="P:positive regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000369">
<property type="term" value="P:regulation of clathrin-dependent endocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032880">
<property type="term" value="P:regulation of protein localization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0168">Coated pit</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0582">Pharmaceutical</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="AP2-associated protein kinase 1" id="PRO_0000250578">
<location>
<begin position="1"/>
<end position="961"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="19">
<location>
<begin position="46"/>
<end position="315"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="19">
<location>
<begin position="52"/>
<end position="60"/>
</location>
</feature>
<feature type="region of interest" description="Clathrin-binding domain (CBD)" evidence="28">
<location>
<begin position="823"/>
<end position="960"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="12"/>
<end position="42"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="397"/>
<end position="614"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="658"/>
<end position="663"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="19 20">
<location>
<position position="176"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="19">
<location>
<position position="74"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="13">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 14">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="235"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="354"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4 5 6 7 9 10">
<location>
<position position="389"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="18">
<location>
<position position="391"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="441"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4 6 10 12 14">
<location>
<position position="606"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="618"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 11 12 14 15">
<location>
<position position="620"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 11">
<location>
<position position="623"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 11 12">
<location>
<position position="624"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 8 9 10 11 12 14">
<location>
<position position="637"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="650"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="653"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9">
<location>
<position position="687"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 9">
<location>
<position position="731"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="846"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="937"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="938"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_039459" evidence="34 35">
<original>EKADVAVESLIPGLEPPVPQRLPSQTESVTSNRTDSLTGEDSLLDCSLLSNPTTDLLEEFAPTAISAPVHKAAEDSNLISGFDVPEGSDKVAEDEFDPIPVLITKNPQGGHSRNSSGSSESSLPNLARSLLLVDQLIDL</original>
<variation>GKVIISVSSVMHDMCACFKNDKYLVNQSLGNSPATPEAKAI</variation>
<location>
<begin position="823"/>
<end position="961"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34535244." id="VAR_040348" evidence="27">
<original>I</original>
<variation>V</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6715776." id="VAR_031129" evidence="21 26">
<original>K</original>
<variation>Q</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1263928487." id="VAR_040349" evidence="27">
<original>Q</original>
<variation>H</variation>
<location>
<position position="533"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56038532." id="VAR_040350" evidence="27">
<original>V</original>
<variation>A</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55889248." id="VAR_040351" evidence="27">
<original>T</original>
<variation>M</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35285785." id="VAR_040352" evidence="27">
<original>P</original>
<variation>T</variation>
<location>
<position position="725"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34422616." id="VAR_040353" evidence="27">
<original>P</original>
<variation>R</variation>
<location>
<position position="771"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_040354" evidence="27">
<original>G</original>
<variation>D</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization. Does not interact with monoubiquitinated NOTCH1." evidence="24 29 30">
<original>K</original>
<variation>A</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization." evidence="24 29">
<original>D</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect interaction with NOTCH1 but abolishes interaction with ESP15." evidence="30">
<original>DPF</original>
<variation>AAA</variation>
<location>
<begin position="777"/>
<end position="779"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="31"/>
<end position="34"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="38"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="44"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="58"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="70"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="81"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="106"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="120"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="134"/>
<end position="139"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="148"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="205"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="210"/>
<end position="220"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="228"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="242"/>
<end position="257"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="261"/>
<end position="264"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="266"/>
<end position="271"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="284"/>
<end position="293"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="304"/>
<end position="315"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="339"/>
<end position="344"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WSQ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5L4Q"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5TE0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19367720"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="F1MH24"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P0C1X8"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q3UHJ0"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10470851"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877457"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877461"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12952931"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14617351"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17494869"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18657069"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21464124"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25653444"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26853940"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31136173"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10470851"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17494869"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000305"/>
<evidence key="38" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="25653444"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="31136173"/>
</source>
</evidence>
<sequence length="961" mass="103885" checksum="1FB44D0FDEF6CAD0" modified="2010-07-13" version="3">MKKFFDSRREQGGSGLGSGSSGGGGSTSGLGSGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGMKCALKRMFVNNEHDLQVCKREIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGSATNKFQNPQTEGVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPFGESQVAICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSYFSFKLLKKECPIPNVQNSPIPAKLPEPVKASEAAAKKTQPKARLTDPIPTTETSIAPRQRPKAGQTQPNPGILPIQPALTPRKRATVQPPPQAAGSSNQPGLLASVPQPKPQAPPSQPLPQTQAKQPQAPPTPQQTPSTQAQGLPAQAQATPQHQQQLFLKQQQQQQQPPPAQQQPAGTFYQQQQAQTQQFQAVHPATQKPAIAQFPVVSQGGSQQQLMQNFYQQQQQQQQQQQQQQLATALHQQQLMTQQAALQQKPTMAAGQQPQPQPAAAPQPAPAQEPAIQAPVRQQPKVQTTPPPAVQGQKVGSLTPPSSPKTQRAGHRRILSDVTHSAVFGVPASKSTQLLQAAAAEASLNKSKSATTTPSGSPRTSQQNVYNPSEGSTWNPFDDDNFSKLTAEELLNKDFAKLGEGKHPEKLGGSAESLIPGFQSTQGDAFATTSFSAGTAEKRKGGQTVDSGLPLLSVSDPFIPLQVPDAPEKLIEGLKSPDTSLLLPDLLPMTDPFGSTSDAVIEKADVAVESLIPGLEPPVPQRLPSQTESVTSNRTDSLTGEDSLLDCSLLSNPTTDLLEEFAPTAISAPVHKAAEDSNLISGFDVPEGSDKVAEDEFDPIPVLITKNPQGGHSRNSSGSSESSLPNLARSLLLVDQLIDL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

